By Paul Lienert (Reuters) – Ford Motor Co has formed a team to accelerate global development of electric vehicles, whose mission will be to “think big” and “make quicker decisions,” an executive of the company said on Monday. One aim of Ford’s “Team Edison” is to identify and develop electric-vehicle partnerships with other companies, including […]
Read More
By Heather Somerville and Anna Irrera SAN FRANCISCO/NEW YORK (Reuters) – Under the leadership of Chief Executive Mike Cagney, Social Finance Inc (SoFi) set its sights on becoming a one-stop shop for every well-to-do millennial looking for financial services and a romantic partner. One of the most valuable private financial technology startups in the […]
Read More
BERLIN (Reuters) – The German state of Baden-Wuerttemberg said it would appeal against a court ruling obliging it to ban diesel cars from the streets of its capital Stuttgart, meaning the ban will not come into force at the start of 2018 as planned. The government of the southwestern region, home to Mercedes-builder Daimler, said […]
Read More By Shereen Lehman (Reuters Health) – Less than an extra hour a week of moderate exercise can make a big difference in helping older adults stay mobile and reduce their risk of developing major mobility problems, a U.S. study suggests. Improvements were seen in all the 70-to-90-year-olds who added some physical activity to their weekly […]
Read More
MANCHESTER, England (Reuters) – Britain will work with industry to launch a deposit return scheme for plastic bottles in a bid to clamp down on the huge waste that litters the land and sea every year, Environment Secretary Michael Gove said on Monday. The government says Britain recycled only 57 percent of the bottles that […]
Read More
NAIROBI (Reuters) – The U.N. World Food Programme is cutting food rations by 30 percent for more than 400,000 refugees living in camps in Kenya due to insufficient funding, it said on Monday. Dadaab and Kakuma camps in Kenya are primarily home to refugees from neighbouring Somalia and South Sudan, both ravaged by wars that […]
Read More
By Chris Prentice and Chris Kahn NEW YORK (Reuters) – A majority of Americans want the U.S. government to require nutrition labels on food packaging, including people who do not read them, according to a Reuters/Ipsos opinion poll released as the Trump administration delays tougher new requirements. The government has delayed the introduction of mandatory labeling […]
Read More By Nina Chestney LONDON (Reuters) – Anglian Water’s issuance of the first water utility green bond in Europe should pave the way for more such instruments which should help the market grow, Dutch bank ING’s head of sustainable capital markets said. Green bonds are a growing category of fixed-income securities, which raise capital for projects […]
Read More
By Jess Macy Yu TAIPEI (Reuters) – Taiwan Semiconductor Manufacturing Co (TSMC) founder and chairman Morris Chang will retire in June, after having built the Apple Inc supplier into the world’s biggest foundry chipmaker with a market value of about $185 billion. Chang, who is 86 and is known as the father of Taiwan’s chip […]
Read More
(Reuters) – Directors at Uber Technologies Inc [UBER.UL] plan to vote on board reforms and whether to pursue a major stock deal with SoftBank Group Corp on Tuesday, Bloomberg reported on Monday, citing sources familiar with the matter. The moves could potentially reshape the ride-hailing company’s governance, limiting co-founder and former Chief Executive Travis Kalanick’s […]
Read More
SHANGHAI (Reuters) – Facebook has taken down a page affiliated with China’s highest profile fugitive, exiled billionaire Guo Wengui, and temporarily restricted his ability to post on his profile, citing violations of its community standards. Guo, who is living in New York, has been using social media to make a series of incendiary, though mostly […]
Read More (Reuters) – Belgian biotech company Ablynx reported resoundingly positive data for an experimental drug against a rare blood disorder on Monday, sending its market value above $1.1 billion. Ablynx said its caplacizumab medicine met the primary and secondary goals in a late-stage trial testing the treatment in patients with acquired thrombotic thrombocytopenic purpura (aTTP). This […]
Read More
